Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malva sylvestris and Alcea digitata formulation versus artificial saliva for radiation-induced xerostomia
IRCT2014012415860N1Phase 2Completed
- Sponsor
- Traditional Medicine & Materia Medica Research Center
- Start
- Feb 2014
- Countries
- 1
01
Overview
Phase 2 trial of alcea digitata + malva sylvestris in radiation-induced hyposalivation (RIX) and head and neck cancer (HNC) (2 arms), sponsored by Traditional Medicine & Materia Medica Research Center. Primary endpoints: Improvement in radiation-induced xerostomia and Quality of life. Started Feb 2014; status: completed.
02
Drugs
alcea digitata + malva sylvestris
03
Conditions
radiation-induced hyposalivation (RIX)head and neck cancer (HNC)
Beyond the preview
Go deeper on IRCT2014012415860N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014012415860N1.